Eric A. Singer

8.1k total citations · 2 hit papers
254 papers, 4.4k citations indexed

About

Eric A. Singer is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Eric A. Singer has authored 254 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Pulmonary and Respiratory Medicine, 77 papers in Molecular Biology and 75 papers in Surgery. Recurrent topics in Eric A. Singer's work include Renal cell carcinoma treatment (92 papers), Renal and related cancers (55 papers) and Bladder and Urothelial Cancer Treatments (47 papers). Eric A. Singer is often cited by papers focused on Renal cell carcinoma treatment (92 papers), Renal and related cancers (55 papers) and Bladder and Urothelial Cancer Treatments (47 papers). Eric A. Singer collaborates with scholars based in United States, South Korea and Canada. Eric A. Singer's co-authors include Ramaprasad Srinivasan, Parth K. Modi, Liliana Soroceanu, Sean D. McAllister, Gennady Bratslavsky, Gopal N. Gupta, Edward M. Messing, Lisa Matlaf, Nicholas Farber and Ganesh S. Palapattu and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Eric A. Singer

240 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study

2021 329 citations Eric A. Singer et al. profile →
Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline

2022 175 citations Eric A. Singer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric A. Singer United States	35	1.9k	1.3k	1.2k	969	653	254	4.4k
Nicola Longo Italy	38	1.6k 0.9×	1.1k 0.8×	987 0.8×	588 0.6×	353 0.5×	242	4.1k
Kenichi Yoshimura Japan	33	1.6k 0.9×	680 0.5×	1.2k 1.0×	1.7k 1.7×	609 0.9×	247	4.5k
Shiro Hinotsu Japan	30	1.2k 0.6×	502 0.4×	1.2k 1.0×	575 0.6×	284 0.4×	198	3.4k
Madhu Mazumdar United States	40	1.2k 0.6×	1.7k 1.3×	2.8k 2.4×	1.3k 1.3×	752 1.2×	87	5.8k
Satoru Kawakami Japan	40	2.2k 1.2×	1.5k 1.1×	1.8k 1.5×	985 1.0×	593 0.9×	251	5.1k
Eliane Angst Switzerland	20	1.1k 0.6×	1.0k 0.8×	1.7k 1.4×	1.7k 1.7×	811 1.2×	36	4.9k
Martin Burchardt Germany	40	1.6k 0.9×	1.5k 1.2×	608 0.5×	500 0.5×	576 0.9×	157	4.5k
Masaki Nakamura Japan	37	1.5k 0.8×	1.4k 1.1×	1.2k 1.0×	1.2k 1.2×	630 1.0×	232	4.5k
J. Brantley Thrasher United States	44	3.2k 1.7×	1.8k 1.4×	1.7k 1.4×	966 1.0×	725 1.1×	134	6.6k
Sung Kyu Hong South Korea	35	3.1k 1.6×	1.1k 0.9×	1.3k 1.1×	679 0.7×	488 0.7×	379	5.3k

Countries citing papers authored by Eric A. Singer

Since Specialization

Citations

This map shows the geographic impact of Eric A. Singer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric A. Singer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric A. Singer more than expected).

Fields of papers citing papers by Eric A. Singer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric A. Singer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric A. Singer. The network helps show where Eric A. Singer may publish in the future.

Co-authorship network of co-authors of Eric A. Singer

This figure shows the co-authorship network connecting the top 25 collaborators of Eric A. Singer. A scholar is included among the top collaborators of Eric A. Singer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric A. Singer. Eric A. Singer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hutson, Thomas E., et al.. (2025). Optimizing Pharmacotherapy During Implementation of Enhanced Recovery After Surgery (ERAS) in Ambulatory Urologic Oncology Surgery: Narrative Review. Cancers. 17(4). 614–614.

Guerrini, Valentina, Brendan Prideaux, Rehan Khan, et al.. (2025). Cryptococcosis, tuberculosis, and a kidney cancer fail to fit the atherosclerosis paradigm for foam cell lipid content. The Journal of Immunology. 214(6). 1358–1369.

Ratan, Aakrosh, Michelle L. Churchman, Laura Graham, et al.. (2025). Clinical and Genomic Features of Androgen Indifferent Prostate Cancer. International Journal of Molecular Sciences. 26(2). 679–679. 1 indexed citations

Zakharia, Yousef, Eric A. Singer, Rohan Garje, et al.. (2024). Durvalumab and guadecitabine in advanced clear cell renal cell carcinoma: results from the phase Ib/II study BTCRC-GU16-043. Nature Communications. 15(1). 972–972. 6 indexed citations

Kohli, Manish, Gregory Riedlinger, Eric A. Singer, et al.. (2024). Activity of Platinum Chemotherapy in Men With Prostate Cancer With and Without DNA Damage Repair Mutations. Clinical Genitourinary Cancer. 23(1). 102293–102293. 1 indexed citations

Singer, Eric A., et al.. (2023). Examining the Role of Microbiota-Centered Interventions in Cancer Therapeutics: Applications for Urothelial Carcinoma. Technology in Cancer Research & Treatment. 22. 2223906084–2223906084. 2 indexed citations

Pfail, John, Hiren V. Patel, Sai Krishnaraya Doppalapudi, et al.. (2023). Pelvic lymphadenectomy: Evaluating nodal stage migration and will rogers effect in bladder cancer. Urologic Oncology Seminars and Original Investigations. 42(1). 21.e9–21.e20. 3 indexed citations

Moughrabi, Samira, et al.. (2023). Publication rates of podium presentations at the Society of Gynecologic Oncology (SGO) annual meetings. International Journal of Gynecological Cancer. 33(8). 1203–1207. 1 indexed citations

Runcie, Karie, et al.. (2023). Systemic Treatment for Advanced and Metastatic Non-Clear Cell Renal Cell Carcinoma: Examining Modern Therapeutic Strategies for a Notoriously Challenging Malignancy. SHILAP Revista de lepidopterología. 10(3). 37–60. 8 indexed citations

10.

Srivastava, Arnav, Hiren V. Patel, Gopal N. Gupta, et al.. (2022). Survival of nonseminomatous germ cell tumors in pediatric patients and young adults – A stage group stratified analysis. Urologic Oncology Seminars and Original Investigations. 40(4). 169.e1–169.e12. 2 indexed citations

11.

Tabakin, Alexandra L., et al.. (2022). Renal Cell Carcinoma with Cardiac Metastases: A Case Report and Review of the Literature. SHILAP Revista de lepidopterología. 9(2). 32–38. 1 indexed citations

12.

Patel, Hiren V., Joshua Sterling, Arnav Srivastava, et al.. (2022). The Impact of Venous Thromboembolism on Mortality and Morbidity During Nephrectomy for Renal Mass. Urology. 168. 122–128. 1 indexed citations

13.

Patel, Hiren V., Sinae Kim, Arnav Srivastava, et al.. (2022). Factors Associated With Palliative Intervention Utilization for Metastatic Renal Cell Carcinoma. Clinical Genitourinary Cancer. 20(3). 296–296.e9. 11 indexed citations

14.

Patel, Hiren V., Arnav Srivastava, Sinae Kim, et al.. (2022). Association of Lymph Node Count and Survival after Primary Retroperitoneal Lymphadenectomy for Nonseminomatous Testicular Cancer. The Journal of Urology. 207(5). 1057–1066. 6 indexed citations

15.

Patel, Hiren V., et al.. (2021). From Diagnosis to Therapy—PET Imaging for Pheochromocytomas and Paragangliomas. Current Urology Reports. 22(1). 2–2. 3 indexed citations

16.

Sterling, Joshua, Zorimar Rivera‐Núñez, Hiren V. Patel, et al.. (2020). Factors Associated With Receipt of Partial Nephrectomy or Minimally Invasive Surgery for Patients With Clinical T1a and T1b Renal Masses: Implications for Regionalization of Care. Clinical Genitourinary Cancer. 18(6). e643–e650. 7 indexed citations

17.

Srivastava, Arnav, Zorimar Rivera‐Núñez, Sinae Kim, et al.. (2020). Impact of pathologic lymph node‐positive renal cell carcinoma on survival in patients without metastasis: Evidence in support of expanding the definition of stage IV kidney cancer. Cancer. 126(13). 2991–3001. 22 indexed citations

18.

Soroceanu, Liliana, Lisa Matlaf, Armin Akhavan, et al.. (2015). Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma. Cancer Research. 75(15). 3065–3076. 68 indexed citations

19.

Hadaczek, Piotr, Tomoko Ozawa, Liliana Soroceanu, et al.. (2013). Cidofovir: A Novel Antitumor Agent for Glioblastoma. Clinical Cancer Research. 19(23). 6473–6483. 57 indexed citations

20.

Soroceanu, Liliana, Ryuichi Murase, Chandani Limbad, et al.. (2012). Id-1 Is a Key Transcriptional Regulator of Glioblastoma Aggressiveness and a Novel Therapeutic Target. Cancer Research. 73(5). 1559–1569. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact